Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains.
- How a new library is set to transform this underserved N.J. community
- Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
- New NJACTS Publication
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
Categories
- Community (2,243)
- Covid (985)
- CTO Events (6)
- News (2,858)
- Pilots (21)